Introduction endent diabetes mellitus which was treated with a sulphonylurea. Plasma creatinine at this point was Patients presenting with renal calculi are routinely 131 mmol/l. screened for hyperoxaluria, defined as the excessive
The patient moved abroad, and in April 1994 preurinary excretion of oxalate anion. The aetiological sented to hospital with pruritus and steatorrhoea. Her diagnosis of hyperoxaluria is very important, since as alkaline phosphatase and aspartate transaminase were well as causing renal disease, hyperoxaluria may reflect elevated. Serological tests for hepatitis A, B and C either potentially lethal genetic disorders of glyoxylate were negative, as were antimitochondrial and antimetabolism (the primary hyperoxalurias) or underlying nuclear antibody assays. A liver ultrasound scan gastrointestinal disease (secondary enteric hyperoxalu-was normal, as was a liver biopsy, and she underria). Other causes of secondary hyperoxaluria include went endoscopic retrograde cholangiopancreatography overconsumption/production of oxalate or its pre-(ERCP ), which demonstrated pancreatic calcification cursors from exogenous sources. The primary hyperox-and some beading of the intrahepatic ducts, raising the alurias are typically associated with nephrolithiasis, possibility of sclerosing cholangitis. Plasma creatinine nephrocalcinosis, renal failure, and systemic deposits was 172 mmol/l and there was no nephrocalcinosis. of calcium oxalate in young people, but the secondary Her symptoms settled without therapy. hyperoxalurias can also cause nephrolithiasis and pro-
The patient returned to the UK in August 1994 and gressive renal disease. Thus the presence of hyperoxalu-was seen at her local hospital, where she reported ria demands effective investigation and therapy. We feeling well and denied gastrointestinal symptoms here describe a patient with primary intestinal lymph-including diarrhoea, steatorrhoea, or abdominal pain. angiectasia who presented with hyperoxaluria and Examination was unremarkable, with normal blood oxalate-induced interstitial nephritis. The diagno-pressure, normal fundi, and no evidence of neuropathy. stic and therapeutic approaches are discussed.
Plasma creatinine was 271 mmol/l, creatinine clearance 19 ml/min with 0.78 g/24 h proteinuria; immunological screening for connective-tissue disease was negative. A therapy with the addition of oral sodium bicarbonate. Serum creatinine fell initially but subsequently rose, and plasma oxalate climbed to a peak of 93 mmol/l. Intensive (daily) haemodialysis was begun in December 1994 in order to reduce plasma oxalate and treat uraemia. There was no evidence of systemic oxalosis on fundoscopy, nerve conduction studies, X-ray skeletal survey, ECG, or echocardiogram. Further investigation to define the cause of the hyperoxaluria was undertaken. Twenty-four-hour urinary oxalate excretion prior to dialysis was 1.06, 1.17 and 0.75 mmol/24 h on three estimates (normal 0.1-0.46) and urinary glycolate was 0.4 and 0.35 mmol/ 24 h (normal 0.1-0.33). L-glycerate was not detected in the urine. Liver biopsy was performed and alanine: glyoxylate aminotransferase (AGT ) activity was 18.5). AGT immunoactivity was positive and immunocytochemical studies showed normal peroxisomal localization of AGT. Hyperoxaluria had thus been laboratory investigations demonstrated plasma creatinine 843 mmol/l, urea 64.9 mmol/l and bicarbonate confirmed, but both type 1 and type 2 primary hyperoxaluria (PH1 and PH2 respectively) were excluded on 7 mmol/l. She was admitted, received intravenous normal saline, and transferred to Hammersmith the basis of AGT assay for PH1, and the absence of glyceric aciduria for PH2. A search for causes of Hospital for further investigation and treatment. She had recently begun insulin therapy for her diabetes but secondary hyperoxaluria was undertaken.
The history was retaken but no new information took no other medication or traditional remedies. There was no family history of renal disease, nephroli-emerged. The patient denied steatorrhoea, weight loss, and abdominal pain and there were no extraintestinal thiasis, or diabetes mellitus.
On arrival she was febrile ( 37.7°C) and had an features of inflammatory bowel disease In view of the dysmorphic facies, karyotype analysis and a dysmorabscess on her forehead. She had evidence of persistent volume depletion with sinus tachycardia, low jugular phology database search were performed but were both normal/negative. Serum B 12 , folate, iron and venous pressure, and postural hypotension. Respiratory, abdominal and neurological examinations were ferritin were normal as were serum immunoglobulins and electrophoresis. There was no Bence Jones prounremarkable. Urinalysis revealed +proteinuria and +glycosuria with 4 white cells per high-power field teinuria and autoimmune profile was negative. A pancreolauryl test and small-bowel follow through and multiple organisms on microscopy. No crystals were seen in the sediment.
were both normal. CT scan of abdomen and pelvis disclosed pancreatic calcification and thickening of the Immediate laboratory investigations showed haemoglobin 8.3 g/dl, white cell count 17.2×109/l (90% neu-duodenal/small bowel wall. A repeat ERCP showed chronic calcific pancreatitis and minor intrahepatic trophils) and normal platelet count and clotting studies. Serum sodium was 141 mmol/l, potassium 4.8 mmol/l, ductal changes, again suggesting possible sclerosing cholangitis. A 3-day faecal fat collection demonstrated urea 36.8 mmol/l, and creatinine 509 mmol/l. Serum albumin was 28 g/l, aspartate transaminase 39 IU/l, steatorrhoea with 36 g fat (normal 0-5 ), and a transferrin-indium scan suggested protein-losing enteropathy alkaline phosphatase 175 IU/l, bilirubin 8 mmol/l, and amylase 15 Somogyi U/dl. The serum C-reactive pro-with only 72% of indium retained (normal >90%).
Duodenal biopsy ( Figure 2) demonstrated the presence tein level was 16 mg/l, glucose 8 mmol/l and glycosylated haemoglobin 8.6%. Arterial blood gases taken of dilated villous and mucosal lymphatic channels with no granulomas. Villi were focally shortened but brush whilst breathing room air revealed pH 7.27, pCO 2 1.88 kPa, pO 2 22.65 kPa, HCO 3 -6.2 mmol/l, base borders preserved, and there was no excess of intraepithelial lymphocytes. There was a moderate increase excess −19.9 mmol/l. An abdominal ultrasound scan showed normal liver and biliary tract and confirmed in acute and chronic inflammatory cells in the lamina propria and focal gastric metaplasia, but no microthe presence of two small kidneys with no pelvicalyceal dilatation or calculi evident. Plasma oxalate was organisms were seen.
A diagnosis of primary intestinal lymphangiectasia 31.2 mmol/l (normal 1-3 mmol/l ). A provisional diagnosis of chronic renal failure due to hyperoxaluria with secondary (enteric) hyperoxaluria and oxalateinduced chronic interstitial nephritis was made. The with interstitial nephritis was made on the basis of the renal biopsy, with an acute deterioration in renal patient remained on relatively high-intensity haemodialysis ( Kt/V=2.0 ) with typical predialysis plasma oxalfunction related to volume depletion and sepsis. The patient received intravenous fluids and antibiotics and ate 21.8 mmol/l and postdialysis 13.2 mmol/l. She received a low-oxalate, low-fat and high-calcium diet underwent surgical drainage of the facial abscess. She commenced a low-oxalate diet and remained on insulin and was treated with insulin and magnesium glycero-the gut or increased oxalate synthesis from exogenous sources (secondary hyperoxaluria).
There are two well-defined types of primary hyperoxaluria ( Figure 3 ) . In type 1 primary hyperoxaluria (PH1), there is deficient activity of the hepatic peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT, EC2.6.1.44), which catalyses the conversion of glyoxylate to glycine, using pyridoxine as a cofactor [3] . Accumulating glyoxylate is oxidized to oxalate by lactate dehydrogenase (LDH, EC 1.1.1.27) and also reduced to glycolate under the catalytic influence of glyoxylate reductase-hyperglycolic aciduria is noted in around 75% of patients with PH1. The calcium salt of glycolate is soluble and causes no tissue damage, unlike calcium oxalate, which has a very low solubility and can precipitate widely. In PH1, calcium oxalate progressively impairing renal function. The combination of oxalate overproduction and reduced excretion phosphate. She was judged to be a suitable candidate accentuates the hyperoxalaemia, resulting in supersatfor renal allotransplantation, but moved abroad in uration of tissue fluids and systemic deposition of late 1995.
calcium oxalate (oxalosis). This usually occurs within the first two decades of life and is associated with peripheral neuropathy, retinopathy, subcutaneous calDiscussion cinosis, synovitis, livedo reticularis, ischaemic vasculitis of the digits, osteodystrophy, and cardiomyopathy. This case is the first description of secondary hyperox-PH1 is caused by mutation of the AGT gene and aluria associated with intestinal lymphangiectasia and has autosomal recessive inheritance. Various mutations illustrates the diagnostic approach to a patient with have been described which can abolish production of hyperoxaluria The renal biopsy provided the clue to protein completely, resulting in synthesis of a nonthe presence of hyperoxaluria in our patient, but it is functional protein, or cause intracellular mis-targeting more often discovered during investigation of nephroli-of the enzyme such that it accumulates in mitochondria thiasis. Oxalate is an inert anion derived mainly from where it cannot function, instead of the usual peroxisoendogenous glyoxylate and ascorbic acid metabolism mal location. ( Figure 3) . In normal subjects, less than 10% of dietary Although rather old for an initial presentation of oxalate is absorbed and contributes little to the sys-PH1 with no appropriate family history, our patient temic oxalate load [1, 2] . Hyperoxaluria represents had a slightly elevated urinary glycolate on one occaexcessive urinary oxalate excretion and can be caused sion and underwent liver biopsy to determine her AGT either by genetic mutations resulting in overproduction activity and localization, both of which were found to of oxalate (primary hyperoxaluria), or acquired condi-be normal. This excluded PH1 as the cause of her tions associated with increased oxalate absorption from hyperoxaluria.
Primary hyperoxaluria type 2 ( PH2) is less common than PH1. It is an autosomal recessive condition caused by mutation in the gene for glyoxylate reductase (GR) which usually reduces glyoxylate to glycolate [5 ] . Glyoxylate, accumulating behind the metabolic block, is converted to oxalate by LDH, resulting in hyperoxaluria. The enzyme GR is identical to D-glycerate dehydrogenase (DGDH ) which catalyses reduction of hydroxypyruvate to to D-glycerate. In PH2, hydroxypyruvate therefore accumulates, and is converted to both L-glycerate (by LDH) and serine (by alanine: hydroxypyruvate aminotransferase). Urinary L-glycerate (absent in normal subjects) and hyperoxaluria are the diagnostic features of PH2. GR assays are possible on systemic leukocyte lysates, but are not widely available. A novel HPLC assay for L-glycerate in body fluids has been proposed by Marangella and colleagues, and it may become possible to demonstrate that many patients labelled as PH1 without enzymological con- Enteric hyperoxaluria and renal failure associated with lymphangiectasia 805 PH2 causes nephrolithiasis and end-stage renal disease, intratubular crystals is the initiating event, crystal growth resulting in tubular rupture and exciting a usually within the first two decades of life, and can also be associated with systemic oxalosis. The absence peritubular inflammatory response leading to interstitial nephritis and subsequent fibrosis [14] . It is of urinary L-glycerate from our patient excluded the diagnosis of PH2.
interesting that some patients develop nephrolithiasis after JIB, whilst others, with similar degrees of hyp-A third form of primary hyperoxaluria has been proposed by Yendt and Cohanim [7] . They described eroxaluria, develop interstitial nephritis. This difference may reflect variation in excretion of urinary inhibitors a 13-year-old girl with hyperoxaluria and calcium oxalate nephrolithiasis, whose hyperoxaluria appeared of stone formation, urine pH, or habitual fluid intake.
An acute renal failure syndrome has been described to respond to thiazides, but insufficient data was given to confidently exclude PH1, PH2 and all causes of in enteric hyperoxaluria by Mandell et al. [18] . A woman with short-bowel syndrome developed acute secondary hyperoxaluria.
The secondary hyperoxalurias are a more heterogen-renal failure in association with volume depletion and renal biopsy demonstrated typical oxalate interstitial eous group -the commonest form being due to excessive absorption of oxalate from the gut (enteric nephritis. It was proposed that hypovolaemia resulted in tubular obstruction by calcium oxalate crystals, with hyperoxaluria). In normal subjects, less than 10% of dietary oxalate is absorbed, but in enteric hyperoxaluria subsequent dissolution of the crystals, resulting in recovery of renal function. Clearly, acute tubular necthis is significantly increased, and up to 60% of intestinal oxalate may be absorbed, as determined by radioisotope rosis may have also played a major part in the pathophysiology of renal failure in this patient. Our patient studies [1, 2 ] . Dietary calcium usually binds to luminal oxalate, forming insoluble calcium oxalate, which passes had an acute exacerbation of renal impairment following volume depletion and sepsis, and similar mechanthrough the gut unabsorbed. In malabsorptive states, an elevated concentration of luminal free long-chain isms may have been operative. Her subsequent recovery was limited, however, and continuing oxalate deposfatty acids saponifies the calcium, making less calcium available for oxalate binding. Consequently, oxalate ition and/or interstitial inflammation resulted in endstage renal disease. hyperabsorption across the colonic mucosa occurs, with a rise in plasma oxalate and associated hyperoxaluria It is of interest that uric acid calculi have been reported in several patients with enteric hyperoxaluria, [1, 8, 9] . Enteric hyperoxaluria occurs in any condition associated with fat malabsorption, e.g. jejuno-ileal as well as the expected calcium oxalate calculi [15, 16 ] .
Urinary urate excretion was not recorded in these bypass (JIB) surgery for obesity, ileal resection, and chronic inflammatory bowel disease. The degree of reports, but would not be expected to increase with steatorrhoea. It is possible that urinary calcium oxalate hyperoxaluria has been found to parallel the magnitude of steatorrhoea in several studies [2, 8, 10 ], but not all may act as a nidus for uric acid calculus formation.
Uric acid calculus formation is increased in urine of [9 ] . Secondary hyperoxaluria is also seen in severe dietary pyridoxine (AGT cofactor) deficiency, and low pH, but this would also not be expected in the presence of tubulointerstitial disease, which often where oxalate precursors are in excess, e.g. consumption of ascorbic acid or ethylene glycol, methoxyfluorane causes renal tubular acidosis.
Apart from general supportive measures, there are use, glycine irrigation of the bladder, and aspergillosis.
Calcium oxalate crystals are seen in the urine almost several specific therapies for enteric hyperoxaluria, aimed at reducing both oxalate absorption from the universally after jejuno-ileal bypass (JIB) performed for obesity, and hyperoxaluria was documented in 60% gut and calcium oxalate crystallization in the urine [19] . A low oxalate diet should be instituted [20 ] , of these patients in one study [11 ] . Calcium oxalate nephrolithiasis is also common in such patients, occur-limiting the enteric oxalate load. To maximize the concentration of calcium in the gut lumen, promoting ring in up to 32% [11 ] . The first description of oxalateinduced interstitial nephritis in association with enteric calcium oxalate salt formation, a diet low in fat and high in calcium should also be provided [21 ] . All hyperoxaluria was by Cryer et al. [12 ] . In 1975 they described a 41-year-old morbidly obese male who attempts should be made to treat the malabsorptive bowel disorder, JIB reversal being the commonest underwent JIB, and 3 years later was found to have hyperoxaluria and significant renal impairment (creati-example, since resolution of steatorrhoea will abolish oxalate hyperabsorption. A seaweed-derived polymer, nine clearance 21 ml/min). He underwent renal biopsy, which demonstrated calcium oxalate deposition and organic marine hydrocolloid, has been used by one group to adsorb intraluminal calcium, trapping bound an associated interstitial nephritis. The JIB was reversed and the hyperoxaluria swiftly returned to oxalate and preventing systemic absorption, although the effect was limited and hyperoxaluria was not fully normal, with stabilization of his renal function. There have been several similar reports [13] [14] [15] [16] [17] , most fre-corrected [22 ] . To minimise urinary precipitation of calcium oxalate, high urinary volumes should be mainquently describing JIB patients, with renal biopsies typically showing intratubular oxalate crystal depos-tained and inhibitors of crystal formation and aggregation used, such as magnesium, orthophosphate and ition with associated giant-cell reaction, tubular destruction, interstitial inflammation and fibrosis. End-citrate [23 ] .
When renal replacement is necessary in enteric hypstage renal disease occurred in several of these cases [14, 16 ] . It has been proposed that the formation of eroxaluria, haemodialysis is usual, since inherent
